NC
CLOV icon

nVerses Capital’s Clover Health Investments CLOV Stock Holding History

nVerses Capital’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.9K Buy
+11,627
New +$39.5K 0.09% 264

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

nVerses Capital's CLOV Position: Q2 2026 in Review

nVerses Capital opened a new position in Clover Health Investments (CLOV) in Q2 2026: 11,627 shares worth $60.9K. The stake represents 0.09% of the portfolio and ranks #264 among its holdings.

169 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • nVerses Capital held 11,627 shares of Clover Health Investments worth $60.9K as of Q2 2026.
  • Clover Health Investments was a new nVerses Capital position in Q2 2026.
  • Clover Health Investments made up 0.09% of nVerses Capital's portfolio in Q2 2026, its #264 holding.
  • 169 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.